Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Old Bridge › NPI 1356828172
Hospital

HMH Hospitals Corporation

HMH Hospitals Corporation was paid $18.66M by Medicaid between Aug 2018 and Dec 2024, across 199 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.

33Billing provider infoHMH HOSPITALS CORPORATION
OLD BRIDGE, NJ 08857
33aNPI1356828172assigned 07/24/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.66M
24GClaims399,688
24DCodes billed199
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#55 of 93
Median peer was paid$30.60M
This provider vs. median0.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20189,573$435K
201947,700$2.55M
202037,327$1.83M
202153,114$2.69M
202279,775$3.41M
202393,679$4.10M
2024incomplete78,520$3.64M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 26% 15,268 13,715 $4.84M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 12,882 11,889 $3.86M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 9.9% 1,370 1,310 $1.84M
G0378 Hospital observation service, per hour 7.0% 2,339 1,861 $1.30M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.2% 3,291 3,113 $597K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.0% 3,079 2,833 $559K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.4% 8,230 1,988 $439K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 2.3% 335 306 $428K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.5% 234 214 $282K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 3,126 1,694 $263K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 1.3% 5,927 1,396 $238K
77067 Screening mammography, bilateral, including computer-aided detection 1.2% 2,007 1,964 $223K
187 more codes
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.2% 6,685 $217K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.0% 2,237 $192K
76642 <1% 1,788 $168K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,698 $163K
80053 Comprehensive metabolic panel <1% 19,395 $153K
70450 Computed tomography, head or brain; without contrast material <1% 3,603 $140K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,885 $130K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,680 $121K
77066 Tomosynthesis, mammo <1% 827 $120K
71046 Radiologic examination, chest; 2 views <1% 5,171 $98K
OP370 <1% 4,785 $94K
OP272 <1% 6,439 $89K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,557 $89K
77065 Tomosynthesis, mammo <1% 745 $84K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 506 $83K
96361 Intravenous infusion, hydration; each additional hour <1% 4,444 $80K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,193 $77K
97010 <1% 7,183 $69K
76830 Ultrasound, transvaginal <1% 862 $68K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,579 $68K
92582 <1% 284 $67K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 634 $60K
36415 Collection of venous blood by venipuncture <1% 21,513 $59K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,457 $57K
71045 Radiologic examination, chest; single view <1% 5,828 $57K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 3,094 $55K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,175 $50K
92567 <1% 803 $49K
96375 Therapeutic injection; each additional sequential IV push <1% 3,985 $49K
82962 <1% 5,698 $33K
97162 <1% 764 $32K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,146 $32K
OP710 <1% 1,312 $31K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 917 $29K
73564 <1% 1,230 $28K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 29 $27K
72110 <1% 850 $27K
92588 <1% 105 $26K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,253 $26K
84484 <1% 8,316 $26K
80048 Basic metabolic panel (calcium, ionized) <1% 4,620 $25K
71275 Computed tomographic angiography, chest, with contrast material <1% 433 $23K
93971 <1% 396 $21K
84443 Thyroid stimulating hormone (TSH) <1% 1,891 $18K
85027 <1% 2,790 $18K
92556 <1% 137 $17K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 159 $17K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,966 $17K
92557 <1% 81 $16K
80061 Lipid panel <1% 1,550 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,596 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 182 $14K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,586 $14K
92550 <1% 131 $14K
83735 <1% 2,986 $13K
OP250 <1% 36,722 $13K
OP258 <1% 19,311 $13K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 392 $12K
73030 <1% 721 $12K
93017 <1% 83 $12K
85610 <1% 2,898 $11K
83690 <1% 5,372 $11K
73630 <1% 934 $11K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,899 $11K
81025 <1% 6,484 $10K
97161 <1% 218 $10K
81001 <1% 5,656 $10K
92579 <1% 53 $9K
72125 Computed tomography, cervical spine; without contrast material <1% 380 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,724 $9K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 425 $9K
85730 <1% 2,418 $9K
88313 <1% 664 $9K
83880 <1% 1,783 $9K
J2704 Injection, propofol, 10 mg <1% 4,318 $8K
83036 Hemoglobin; glycosylated (A1C) <1% 1,243 $8K
73610 <1% 745 $7K
88312 <1% 878 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 88 $7K
88342 <1% 445 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,245 $6K
81003 <1% 4,193 $6K
73130 <1% 457 $6K
96376 <1% 804 $6K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,153 $6K
OP270 <1% 3,040 $6K
90791 Psychiatric diagnostic evaluation <1% 334 $5K
93970 <1% 28 $5K
0012A <1% 204 $5K
70551 Magnetic resonance imaging, brain; without contrast material <1% 41 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,006 $5K
95800 <1% 12 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,349 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 961 $5K
82607 <1% 461 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 313 $5K
0011A <1% 177 $4K
90715 <1% 344 $4K
84439 <1% 577 $4K
77080 <1% 41 $3K
74018 <1% 187 $3K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 32 $3K
0064A <1% 108 $3K
0002A <1% 86 $3K
72052 <1% 57 $3K
82948 <1% 176 $3K
0001A <1% 84 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 625 $3K
82077 <1% 1,350 $3K
87070 <1% 1,285 $2K
86850 <1% 804 $2K
0004A <1% 63 $2K
85379 <1% 1,328 $2K
J3490 Unclassified drugs <1% 886 $2K
0071A <1% 38 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 405 $2K
86900 <1% 810 $2K
0072A <1% 34 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,340 $1K
86901 <1% 810 $1K
85007 <1% 95 $1K
73110 <1% 107 $1K
87040 <1% 256 $1K
76536 <1% 14 $1K
87400 <1% 536 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 488 $918.63
92593 <1% 15 $840.07
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 123 $834.96
83605 <1% 177 $801.40
J0690 Injection, cefazolin sodium, 500 mg <1% 620 $780.56
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 51 $684.43
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 13 $631.62
V5020 Conformity evaluation <1% 26 $615.20
82550 <1% 582 $544.01
73502 <1% 76 $533.84
84100 <1% 659 $516.97
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,240 $466.65
J2060 Injection, lorazepam, 2 mg <1% 418 $448.98
80306 <1% 225 $437.56
A4618 Breathing circuits <1% 631 $437.03
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 227 $424.72
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 710 $423.53
82746 <1% 40 $387.79
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 375 $384.78
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 183 $365.51
85651 <1% 351 $356.60
80143 <1% 225 $332.99
80179 <1% 169 $318.08
84702 <1% 90 $287.51
0124A <1% 16 $249.17
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 32 $241.39
C9113 Injection, pantoprazole sodium, per vial <1% 501 $200.84
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 743 $195.84
73080 <1% 12 $176.79
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 348 $172.60
87186 <1% 114 $158.30
J1815 Injection, insulin, per 5 units <1% 34 $146.48
71101 <1% 25 $142.19
90792 Psychiatric diagnostic evaluation with medical services <1% 49 $131.87
J1650 Injection, enoxaparin sodium, 10 mg <1% 260 $109.98
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 94 $104.64
88341 <1% 24 $101.13
J1644 Injection, heparin sodium, per 1000 units <1% 146 $75.81
84550 <1% 33 $62.15
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 40 $58.64
87088 <1% 69 $52.17
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 16 $38.00
91301 <1% 354 $38.00
J2470 Injection, pantoprazole sodium, 40 mg <1% 114 $37.96
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 69 $35.73
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 23 $28.06
97116 <1% 32 $24.97
J1171 Injection, hydromorphone, 0.1 mg <1% 23 $24.92
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 185 $17.06
J3475 Injection, magnesium sulfate, per 500 mg <1% 33 $16.82
82040 <1% 19 $12.67
96367 <1% 16 $9.27
80076 <1% 19 $8.96
OP637 <1% 3,749 $7.08
91300 <1% 218 $5.00
91307 <1% 43 $3.00
91306 <1% 98 $2.00
J1630 Injection, haloperidol, up to 5 mg <1% 12 $1.73
74022 0% 12 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 13 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 13 $0.00
91312 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAWCZUK, IHOR (PRESIDENT)
Same official

Other billing entities under SAWCZUK, IHOR

Full network →
ProviderLocationPaid
HMH Hospitals CorporationHackensack, NJ$333.03M
HMH Hospitals CorporationNorth Bergen, NJ$79.26M
HMH Hospitals CorporationPerth Amboy, NJ$65.37M
HMH Hospitals CorporationBrick, NJ$49.91M
HMH Hospitals CorporationHolmdel, NJ$29.33M
HMH Hospitals CorporationRed Bank, NJ$26.39M
HMH Hospitals CorporationBrick, NJ$575K
Hackensack Specialty Care Associates, PCHackensack, NJ$141K
Humc Medical ObservationHackensack, NJ$14K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.